MMV Financial specializes in providing timely and efficient growth capital to emerging technology and life sciences companies in North America. They have a range of debt financing approaches that allow companies to access additional capital without significant dilution. Their quick and user-friendly process enables them to deploy capital within four weeks of signing a term sheet. MMV Financial does not require board representation or the renegotiation of shareholder agreements, and they do not impose financial covenants or guarantees. They focus on companies with proprietary products or processes that differentiate themselves from competitors. They have financed a wide range of companies, from early-stage startups to those with over $90 million in annual revenue. MMV Financial's goal is to provide entrepreneurs with the capital they need to grow their businesses while minimizing dilution and allowing management to remain focused on their core operations.